NCT05385601

Brief Summary

This study aims to compare measurements obtained through the e-VOG application (mobile application, usable on smartphones or tablets, to record eye movements) with measurements from the standard video-oculography device (Eye-Tracker®T2), in young athletes. This study also aims to correlate these measurements with volumetric data from cerebral imaging (if MRI done in routine care at the same period, more or less 1 month).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 17, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 18, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 23, 2022

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 8, 2022

Completed
Last Updated

July 20, 2022

Status Verified

July 1, 2022

Enrollment Period

22 days

First QC Date

May 18, 2022

Last Update Submit

July 19, 2022

Conditions

Keywords

Young athletes

Outcome Measures

Primary Outcomes (1)

  • Oculomotor profiles concordance

    Analyze of the concordance of the profiles obtained between the e-VOG digital assessment and the standard video-oculography assessment. Evaluation criteria: For each assessment, patients will be classified according to the number of oculomotor abnormality observed (based on identified parameters assessments: latency / speed / gain / altered ocular pursuits / fixation disorders / presence of internuclear ophthalmoplegia), in accordance with the literature standards

    Day 0

Secondary Outcomes (17)

  • Latency during horizontal reflex saccades

    Day 0

  • Latency during vertical reflex saccades

    Day 0

  • Latency during horizontal voluntary saccades

    Day 0

  • Velocity during horizontal reflex saccades

    Day 0

  • Velocity during vertical reflex saccades

    Day 0

  • +12 more secondary outcomes

Study Arms (2)

Healthy young athletes (Eye-Tracker®T2 + e-VOG)

Subjects who first perform standard video-oculography assessment, followed by e-VOG digital assessment.

Other: eVOG (Mobile VideoOculoGraphy)

Healthy young athletes (e-VOG + Eye-Tracker®T2)

Subjects who first perform e-VOG digital assessment, followed by the standard video-oculography assessment.

Other: eVOG (Mobile VideoOculoGraphy)

Interventions

* Eyes movements assessed with e-VOG (mobile application developed on an iPad, that uses the face detection features of the front camera to detect and record eye movements). * Study duration is about 20 minutes, the day the subject performs his standard video-oculography examination in routine care (using Eye-Tracker®T2)

Healthy young athletes (Eye-Tracker®T2 + e-VOG)Healthy young athletes (e-VOG + Eye-Tracker®T2)

Eligibility Criteria

Age15 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Young athletes for whom a standard video-oculography exam is prescribed by the AS Monaco Football medical Team as part of a preventive and follow-up approach performed in routine care.

You may qualify if:

  • Young Athletes from AS Monaco Academy
  • referred by AS Monaco Medical Team to perform a video-oculography (Eye-Tracking) examination as part of routine care.
  • covered by a health insurance system
  • volunteer, able to give free, informed and written consent.

You may not qualify if:

  • General anaesthesia within 3 months.
  • Head trauma within 3 months
  • Neurological, ophthalmological or general pathology preventing the realization of a video-oculography examination.
  • Oculomotor abnormality detectable on clinical examination by the neurologist prescribing the standard video-oculography examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Mémoire / Centre de Gérontologie Clinique Rainier III / Princess Grace Hospital

Monaco, 98000, Monaco

Location

Study Officials

  • Mikael COHEN, MD

    Centre de Ressources et de Compétences SEP, UMRC Pasteur 2, Université Nice Côte d'Azur, Nice-France

    PRINCIPAL INVESTIGATOR
  • Sandrine LOUCHART DE LA CHAPELLE, MD-PHD

    Centre Mémoire, Centre de Gérontologie Clinique RAINIER III, Princess Grace Hospital, Monaco

    PRINCIPAL INVESTIGATOR
  • Alain PESCE, MD-PHD

    AREBISN (Association de Recherche Bibliographique pour les Neurosciences), Nice (France)

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2022

First Posted

May 23, 2022

Study Start

May 17, 2022

Primary Completion

June 8, 2022

Study Completion

June 8, 2022

Last Updated

July 20, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations